ArticleMolecular cancer therapeutics2012

In silico screening reveals structurally diverse, nanomolar inhibitors of NQO2 that are functionally active in cells and can modulate NF-κB signaling.

Karen A Nolan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.